Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:



Creation of a Health Data Agency in Belgium – A key agency for the future European Health Data Space

On January 17th, 2024, Belgium welcomed the official launch of the Belgian Health Data Agency. This Agency aims to enhance the availability and utilisation of health data and healthcare...


BIOSECURE Act aims to restrict funding and genetic data use by foreign adversary biotech companies

The BIOSECURE Act (the “Act”), introduced by members of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party...


The False Claims Act Guide: 2023 and the road ahead

In the latest edition of our False Claims Act Guide: 2023 and the road ahead, we analyze the key developments from 2023 and discuss how the most important cases and issues are shaping FCA...

Insights and Analysis

Webinar: Data protection in the Middle East and Africa feat. Nigerian Data Protection Commissioner

The "new normal" of global data protection regulation is becoming increasingly complex. With 37 African countries having a comprehensive data protection legal framework and the...


The EU AI Act: an impact analysis (part 1)

In December 2023, political agreement was reached by EU policy makers on all substantive aspects of the EU Artificial Intelligence Act. Since then, the close-to-final text of this...

Insights and Analysis

Life Science Law Update – Key developments for pharma & device companies in EU and EU Big Five
Registered Content

In this Q4/23 issue of our Life Science and Health Care Law Update, our teams highlight key trends across life sciences regulatory, corporate, compliance, competition, and privacy...


Digital Transformation: AI Act – The European approach on regulating AI

Following the political agreement between the EU Parliament and Council in December 2023, the EU AI Act is set to become the new key pillar of the EU’s AI strategy. The AI Act is...


Digital Transformation: The Influencers Podcast

In this latest episode of The Influencers, Eva-Valérie Gfrerer, Founder & CEO of Morphais, and Hogan Lovells host Leopold von Gerlach dissect how using data-driven investing ...


FDA permits IRB informed consent waivers for minimal risk clinical trials

The U.S. Food and Drug Administration (FDA) has published a final rule on “Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical...

Loading data